SynteractHCR is a full-service contract research organization with a successful two-decade plus track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its ñShared Work _ Shared Visionî philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster. Our mission is to support the innovation and development of better therapies in healthcare. Our focus on patientsÍ safety and comfort helps us to establish ethical standards for everything we do.